ストックスクリーナーアプリを入手
146.44
0.95%
1.38
アフターアワーズ：
146.40
-0.04
-0.03%
前日終値:
$145.06
開ける：
$145.06
24時間の取引高:
1.37M
Relative Volume:
0.87
時価総額：
$10.16B
収益：
$2.90B
当期純損益:
$302.80M
株価収益率:
34.08
EPS:
4.2965
ネットキャッシュフロー:
$387.80M
1週間 パフォーマンス:
+5.13%
1か月 パフォーマンス:
-9.64%
6か月 パフォーマンス:
-39.67%
1年 パフォーマンス:
-52.56%
1日の値動き範囲:
$143.12
$146.82
1週間の範囲:
$136.46
$146.82
52週間の値動き範囲:
$126.40
$354.88
Insulet Corp Stock (PODD) Company Profile
Compare PODD vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corp
|
146.44 | 10.06B | 2.90B | 302.80M | 387.80M | 4.2965 |
ABT
Abbott Laboratories
|
111.27 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
341.09 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.58 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.69 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.56 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Insulet Corp Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-24 | ダウングレード | Rothschild & Co Redburn | Buy → Neutral |
| 2026-04-07 | ダウングレード | Citigroup | Buy → Neutral |
| 2026-01-27 | 再開されました | TD Cowen | Hold |
| 2026-01-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-12-16 | 開始されました | Evercore ISI | Outperform |
| 2025-11-19 | アップグレード | UBS | Neutral → Buy |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | 再開されました | Oppenheimer | Outperform |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-05-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corp (PODD) 最新ニュース
PODD IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Insulet Corporation ... - Caledonian Record
Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation ... - Caledonian Record
Important Notice to Long-Term Shareholders of Bloom Energy - GlobeNewswire
Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier - Yahoo Finance
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Insulet hires Pfizer alum Joan Campion to lead external comms - Medical Marketing and Media
Insulet (PODD) Q2 2026 Earnings Call Transcript - AOL.com
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Important Notice to Long-Term Shareholders of Erasca, Inc. - GlobeNewswire
Insulet Corporation (NASDAQ:PODD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Insulet Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Bank of America Corp DE Sells 61,769 Shares of Insulet Corporation $PODD - MarketBeat
Insulet (NASDAQ:PODD) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beacon Investment Advisory Services Inc. Has $9.03 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PO - The National Law Review
PODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds - The National Law Review
PODD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds In - The National Law Review
PODD Maintained by TD Cowen -- Price Target Lowered to $144 - GuruFocus
Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious - Yahoo Finance
Insulet (NASDAQ:PODD) Price Target Lowered to $144.00 at TD Cowen - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $150.00 at UBS Group - MarketBeat
Insulet (NASDAQ:PODD) Given New $185.00 Price Target at Benchmark - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $180.00 at Stifel Nicolaus - MarketBeat
FMR LLC (PODD) reports 964,296 Insulet Corp shares in amended 13G filing - Stock Titan
Raymond James cuts Insulet stock price target on type 2 attrition - Investing.com
PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities LawsuitContact Levi & Korsinsky - Business Wire
Why is Insulet stock sliding today? - Investing.com
JPMorgan cuts Insulet to neutral on slowing U.S. growth, trims target by 45% - Yahoo! Finance Canada
Canaccord cuts Insulet stock price target to $179 on retention issues - Investing.com
Insulet (NASDAQ:PODD) Cut to Market Perform at Leerink Partners - marketbeat.com
Insulet (NASDAQ:PODD) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat
Here Are Thursday’s Top Wall Street Analyst Research Calls: AppLovin, Charles River, Global Payments, HubSpot, Insulet Corporation, Roper Technologies, Sabra Health Care, Western Digital, Zillow Group, and More - 24/7 Wall St.
These Analysts Slash Their Forecasts On Insulet After Q2 Results - Benzinga
Wells Fargo cuts Insulet stock rating on attrition concerns - Investing.com
Insulet (PODD) Is Down 21.9% After Cutting 2026 Revenue Outlook On Weaker Type 2 Retention - Yahoo Finance
A Look at Insulet Corp (PODD) After 20.1% Decline -- GF Value $4 - GuruFocus
Insulet Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Insulet Earnings: Solid Quarterly Results Give Way to Impending Deceleration in Second Half - Morningstar
Insulet Stock Crashes as Tiny Guidance Cut Changes the Story - Yahoo Finance
Insulet Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
U.S. Indexes Finished Mixed Wednesday As Shopify Led, Insulet Lagged - Barron's
Insulet Corp 2Q 2026: Revenue $801.7M, EPS $1.37— 10-Q Summary - TradingView
Insulet Gears Up to Face Heightened Competition in 2027 - Morningstar
Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth Offset by Type 2 ... - Yahoo Finance
Insulet Corp (PODD) (Q2 2026) Earnings Call Highlights: Strong R - GuruFocus
Insulet Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Insulet Q2 2026 beat overshadowed by guidance cut - Investing.com
Insulet Corporation stock hits 52-week low at $127.56 - Investing.com
Insulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is Lowered - Yahoo Finance
Insulet Corp (PODD) 財務データ
収益
当期純利益
現金流量
EPS
1.72%
0.22%
大文字化:
|
ボリューム (24 時間):